These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30360505)

  • 1. Shiga Toxin-Producing
    Sacerdoti F; Scalise ML; Burdet J; Amaral MM; Franchi AM; Ibarra C
    Microorganisms; 2018 Oct; 6(4):. PubMed ID: 30360505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin producing
    Falup-Pecurariu O; Lixandru RI; Cojocaru E; Csutak K; Monescu V; Muhsen K; Falup-Pecurariu C; Cohen D
    Gut Pathog; 2019; 11():46. PubMed ID: 31572497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and characteristics of Shiga toxin-producing Escherichia coli isolated by the enteric pathogens active surveillance network (Enter-Net) in the Republic of Korea, 2009-2018.
    Yun YS; Kim NO; Chun JH; Hwang KJ; Hong S
    Microb Pathog; 2021 Sep; 158():105005. PubMed ID: 34044043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
    Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
    mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal administration of shiga toxin type 2 in rats in the late stage of pregnancy produces premature delivery of dead fetuses.
    Burdet J; Zotta E; Franchi AM; Ibarra C
    Placenta; 2009 Jun; 30(6):491-6. PubMed ID: 19395083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli: a world in motion.
    Tozzoli R; Grande L; Michelacci V; Ranieri P; Maugliani A; Caprioli A; Morabito S
    Front Cell Infect Microbiol; 2014; 4():80. PubMed ID: 24999453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes.
    Olavesen KK; Lindstedt BA; Løbersli I; Brandal LT
    Microb Pathog; 2016 Aug; 97():1-8. PubMed ID: 27208749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and characterization of circulating microvesicles containing Shiga toxin type 2 in a rat model of Hemolytic Uremic Syndrome.
    Sacerdoti F; Gomez FD; Jancic C; Lombardo T; Pascuale CA; Moretton MA; Chiappetta DA; Ibarra C; Amaral MM
    Toxicon; 2023 Dec; 236():107349. PubMed ID: 37979924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.
    Melton-Celsa AR; Carvalho HM; Thuning-Roberson C; O'Brien AD
    Clin Vaccine Immunol; 2015 Apr; 22(4):448-55. PubMed ID: 25716230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga Toxin-Producing Escherichia coli in Feces of Finisher Pigs: Isolation, Identification, and Public Health Implications of Major and Minor Serogroups†.
    Remfry SE; Amachawadi RG; Shi X; Bai J; Tokach MD; Dritz SS; Goodband RD; Derouchey JM; Woodworth JC; Nagaraja TG
    J Food Prot; 2021 Jan; 84(1):169-180. PubMed ID: 33411931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
    Trials; 2023 May; 24(1):359. PubMed ID: 37245030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
    Jeong KI; Tzipori S; Sheoran AS
    J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.
    Leotta GA; Miliwebsky ES; Chinen I; Espinosa EM; Azzopardi K; Tennant SM; Robins-Browne RM; Rivas M
    BMC Microbiol; 2008 Mar; 8():46. PubMed ID: 18366637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.